申请人:ASTRAZENECA AB
公开号:WO2005042502A1
公开(公告)日:2005-05-12
The invention concerns a compound of the Formula (I) wherein m is 0-2 and each R1 is a group such as hydroxy, halogeno, trifluoromethyl heterocyclyl and heterocyclyloxy; R2 is halogeno, trifluoromethyl or (1-6C)alkyl; R3 is hydrogen, halogeno or (1-6C)alkyl; and R4 is (3-6C)cycloalkyl;or pharmaceutically-acceptable salts thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical condions mediated by cytokines.
本发明涉及一种公式(I)的化合物,其中m为0-2,每个R1均为诸如羟基、卤素、三氟甲基杂环和杂环氧基的基团;R2是卤素、三氟甲基或(1-6C)烷基;R3是氢、卤素或(1-6C)烷基;R4是(3-6C)环烷基;或其药用可接受的盐;其制备过程、含有它们的药物组合物以及它们在治疗由细胞因子介导的疾病或医疗状况中的用途。